C159H177N21O21 — CID 158144699
N-[(1R)-1-[3-(cyclopentylcarbamoyl)phenyl]ethyl]-2-(2-methoxyethoxy)-4-(1H-pyrazol-4-yl)benzamide;N-[(1R)-1-[3-(cyclopentylcarbamoyl)phenyl]ethyl]-2-methoxy-4-(1H-pyrazol-4-yl)benzamide;N-[(1S)-1-[3-(cyclopentylcarbamoyl)phenyl]-2-hydroxyethyl]-2-ethyl-4-pyridin-4-ylbenzamide;N-[(1S)-1-[3-(cyclopentylcarbamoyl)phenyl]-2-hydroxyethyl]-2-(methoxymethyl)-4-pyridin-4-ylbenzamide;N-[(1S)-1-[3-(cyclopentylcarbamoyl)phenyl]-2-hydroxyethyl]-2-methoxy-4-pyridin-4-ylbenzamide;N-[(1S)-1-[3-(cyclopentylcarbamoyl)phenyl]-2-hydroxyethyl]-3-(1H-pyrazol-4-yl)benzamide (PubChem CID 158144699) has the molecular formula C159H177N21O21 and a molecular weight of 2718.29 g/mol. Its IUPAC name is N-[(1R)-1-[3-(cyclopentylcarbamoyl)phenyl]ethyl]-2-(2-methoxyethoxy)-4-(1H-pyrazol-4-yl)benzamide;N-[(1R)-1-[3-(cyclopentylcarbamoyl)phenyl]ethyl]-2-methoxy-4-(1H-pyrazol-4-yl)benzamide;N-[(1S)-1-[3-(cyclopentylcarbamoyl)phenyl]-2-hydroxyethyl]-2-ethyl-4-pyridin-4-ylbenzamide;N-[(1S)-1-[3-(cyclopentylcarbamoyl)phenyl]-2-hydroxyethyl]-2-(methoxymethyl)-4-pyridin-4-ylbenzamide;N-[(1S)-1-[3-(cyclopentylcarbamoyl)phenyl]-2-hydroxyethyl]-2-methoxy-4-pyridin-4-ylbenzamide;N-[(1S)-1-[3-(cyclopentylcarbamoyl)phenyl]-2-hydroxyethyl]-3-(1H-pyrazol-4-yl)benzamide.
| Compound Name | N-[(1R)-1-[3-(cyclopentylcarbamoyl)phenyl]ethyl]-2-(2-methoxyethoxy)-4-(1H-pyrazol-4-yl)benzamide;N-[(1R)-1-[3-(cyclopentylcarbamoyl)phenyl]ethyl]-2-methoxy-4-(1H-pyrazol-4-yl)benzamide;N-[(1S)-1-[3-(cyclopentylcarbamoyl)phenyl]-2-hydroxyethyl]-2-ethyl-4-pyridin-4-ylbenzamide;N-[(1S)-1-[3-(cyclopentylcarbamoyl)phenyl]-2-hydroxyethyl]-2-(methoxymethyl)-4-pyridin-4-ylbenzamide;N-[(1S)-1-[3-(cyclopentylcarbamoyl)phenyl]-2-hydroxyethyl]-2-methoxy-4-pyridin-4-ylbenzamide;N-[(1S)-1-[3-(cyclopentylcarbamoyl)phenyl]-2-hydroxyethyl]-3-(1H-pyrazol-4-yl)benzamide |
|---|---|
| PubChem CID | 158144699 |
| Molecular Formula | C159H177N21O21 |
| Molecular Weight | 2718.29 g/mol |
| Exact Mass | 2716.34 |
| IUPAC Name | N-[(1R)-1-[3-(cyclopentylcarbamoyl)phenyl]ethyl]-2-(2-methoxyethoxy)-4-(1H-pyrazol-4-yl)benzamide;N-[(1R)-1-[3-(cyclopentylcarbamoyl)phenyl]ethyl]-2-methoxy-4-(1H-pyrazol-4-yl)benzamide;N-[(1S)-1-[3-(cyclopentylcarbamoyl)phenyl]-2-hydroxyethyl]-2-ethyl-4-pyridin-4-ylbenzamide;N-[(1S)-1-[3-(cyclopentylcarbamoyl)phenyl]-2-hydroxyethyl]-2-(methoxymethyl)-4-pyridin-4-ylbenzamide;N-[(1S)-1-[3-(cyclopentylcarbamoyl)phenyl]-2-hydroxyethyl]-2-methoxy-4-pyridin-4-ylbenzamide;N-[(1S)-1-[3-(cyclopentylcarbamoyl)phenyl]-2-hydroxyethyl]-3-(1H-pyrazol-4-yl)benzamide |
| SMILES | CCc1cc(-c2ccncc2)ccc1C(=O)N[C@H](CO)c1cccc(C(=O)NC2CCCC2)c1.COCCOc1cc(-c2cn[nH]c2)ccc1C(=O)N[C@H](C)c1cccc(C(=O)NC2CCCC2)c1.COCc1cc(-c2ccncc2)ccc1C(=O)N[C@H](CO)c1cccc(C(=O)NC2CCCC2)c1.COc1cc(-c2ccncc2)ccc1C(=O)N[C@H](CO)c1cccc(C(=O)NC2CCCC2)c1.COc1cc(-c2cn[nH]c2)ccc1C(=O)N[C@H](C)c1cccc(C(=O)NC2CCCC2)c1.O=C(NC1CCCC1)c1cccc([C@@H](CO)NC(=O)c2cccc(-c3cn[nH]c3)c2)c1 |
| InChI | InChI=1S/C28H31N3O4.C28H31N3O3.C27H32N4O4.C27H29N3O4.C25H28N4O3.C24H26N4O3/c1-35-18-23-15-20(19-11-13-29-14-12-19)9-10-25(23)28(34)31-26(17-32)21-5-4-6-22(16-21)27(33)30-24-7-2-3-8-24;1-2-19-16-21(20-12-14-29-15-13-20)10-11-25(19)28(34)31-26(18-32)22-6-5-7-23(17-22)27(33)30-24-8-3-4-9-24;1-18(19-6-5-7-21(14-19)26(32)31-23-8-3-4-9-23)30-27(33)24-11-10-20(22-16-28-29-17-22)15-25(24)35-13-12-34-2;1-34-25-16-19(18-11-13-28-14-12-18)9-10-23(25)27(33)30-24(17-31)20-5-4-6-21(15-20)26(32)29-22-7-2-3-8-22;1-16(17-6-5-7-19(12-17)24(30)29-21-8-3-4-9-21)28-25(31)22-11-10-18(13-23(22)32-2)20-14-26-27-15-20;29-15-22(17-6-4-8-19(12-17)23(30)27-21-9-1-2-10-21)28-24(31)18-7-3-5-16(11-18)20-13-25-26-14-20/h4-6,9-16,24,26,32H,2-3,7-8,17-18H2,1H3,(H,30,33)(H,31,34);5-7,10-17,24,26,32H,2-4,8-9,18H2,1H3,(H,30,33)(H,31,34);5-7,10-11,14-18,23H,3-4,8-9,12-13H2,1-2H3,(H,28,29)(H,30,33)(H,31,32);4-6,9-16,22,24,31H,2-3,7-8,17H2,1H3,(H,29,32)(H,30,33);5-7,10-16,21H,3-4,8-9H2,1-2H3,(H,26,27)(H,28,31)(H,29,30);3-8,11-14,21-22,29H,1-2,9-10,15H2,(H,25,26)(H,27,30)(H,28,31)/t2*26-;18-;24-;16-;22-/m111111/s1 |
| InChIKey | FUJGTNZHJZFSNO-MHBXYFSMSA-N |
| XLogP | 24.10 |
| TPSA | 600.98 Ų |
| H-Bond Donors | 19 |
| H-Bond Acceptors | 27 |
| Rotatable Bonds | 49 |
| Heavy Atoms | 201 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2718.29 |
| LogP ≤ 5 | 24.10 |
| H-Bond Donors ≤ 5 | 19 |
| H-Bond Acceptors ≤ 10 | 27 |
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|